In vitro Antileishmanial and Antimalarial Activities of Tetrahydrofuran Lignans isolated from Nectandra megapotamica (Lauraceae)


Autoria(s): SILVA FILHO, Ademar A. da; COSTA, Eveline S.; CUNHA, Wilson R.; SILVA, Marcio L. A. e.; NANAYAKKARA, N. P. Dhammika; BASTOS, Jairo K.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

Seven tetrahydrofuran lignans, isolated from Nectandra megapotamica (Lauraceae), were evaluated for their in vitro antileishmanial and antimalarial activities. Among the evaluated compounds, machilin-G (1a) and veraguensin (2a) showed the highest antileishmanial activities, displaying for both compounds an IC(50) value of 18 mu g/mL and an IC(50) value of 36 mu g/mL, while galgravin (1b), nectandrin-A (1c), nectandrin-B (1d), calopeptin (2b) and ganshisandrine (3) were inactive against Leishmania donovani. In the antimalarial assay against Plasmodium falciparum, it was observed that calopeptin (2b) displayed moderate activity, with IC(50) values of 3800 ng/mL (136 clone) and 3900 ng/mL (W2 clone), while the lignans 1a-1d, 2a and 3 were inactive. In order to compare the effect on the parasites with toxicity to mammalian cells, the cytotoxic activity of the isolated compounds were evaluated against the Vero cells, showing that all evaluated tetrahydrofuran lignans exhibited no cytotoxicity at the maximum dose tested. Copyright (C) 2008 John Wiley & Sons, Ltd.

CAPES[PDEE/BEX 0387/04-5]

FAPESP[01/14209-7]

Identificador

PHYTOTHERAPY RESEARCH, v.22, n.10, p.1307-1310, 2008

0951-418X

http://producao.usp.br/handle/BDPI/20074

10.1002/ptr.2486

http://dx.doi.org/10.1002/ptr.2486

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

Relação

Phytotherapy Research

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #Nectandra megapotanzica #tetrahydrofuran lignans #Leishmania donovani #Plasmodium falciparum #TRYPANOCIDAL ACTIVITY #VIROLA-SURINAMENSIS #PLANTS #CONSTITUENTS #ALKALOIDS #EXTRACT #ROOTS #Chemistry, Medicinal #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion